Immuno-Oncology Enhances Battlespace Awareness
Molecular Imaging Could Help Clinicians Accurately Select Patients for Treatment or Monitoring
Why Cardiology Is Ripe to Become the Next Frontier for Precision Medicine
Cardiovascular Disease Applications Are Set to Focus on Highly Individualized Variables for Therapy
The Top 15 Best-Selling Drugs of 2017
Amid Talk of Curbing Prices, Most Treatments Show Sales Gains
Cell Therapy Production Moves to Factory Floor
Assembly Lines Are Preparing to Churn out Safe, Reliable, and Affordable Constructs
For full access to this article login to GEN Select now.
Fine-Tuning the Design of GPCR Therapeutics
Understanding Allosteric Modulation and Functional Selectivity Are Key Priorities
- Bryan Roth, M.D., Ph.D., director of the National Institute of Mental Health’s psychoactive drug screening program at the University of North Carolina, suggests that the information printed in textbooks of pharmacology is “far from reality.” He is referring to recent discoveries about the incredible complexity of GPCR, the theme ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.